Healthpeak Properties, Inc.
DOC Real Estate REIT - Healthcare Facilities NYSE
$17.28
$-0.13 (-0.75%)
Open: $17.11 | High: $17.38 | Low: $16.96 | Prev Close: $17.41
Market Cap: $12.01B
Volume: 5.1M | Avg: 9.2M
Last updated: March 09, 2026 at 02:01 AMInvestment Rating
Sell
Overall Score: 40/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 452
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 172.80 |
| P/B Ratio | 1.60 |
| P/S Ratio | 4.26 |
| EPS | $0.10 |
| Beta | 1.08 |
| Shares Outstanding | 695.04M |
| 52-Week High | $21.28 |
| 52-Week Low | $15.71 |
| SMA 50 | $17.03 |
| SMA 200 | $17.58 |
| Dividend Yield | 6.47% |
| Annual Dividend | $1.12 |
| Next Earnings | April 23, 2026 09:00 PM ET |
Financial Ratios
| Gross Margin | 22.5% |
| Operating Margin | 19.3% |
| Net Margin | 2.5% |
| ROE | 0.9% |
| ROA | 0.4% |
| Debt/Equity | 1.39 |
| Current Ratio | 1.09 |
| Quick Ratio | 1.09 |
Balance Sheet
| Total Assets | $20.34B |
| Total Liabilities | $12.03B |
| Total Equity | $7.50B |
|
|
|
| Cash | $537.70M |
| Total Debt | $10.44B |
| Net Debt | $9.90B |
Income Statement
| Revenue | $2.82B |
| Gross Profit | $634.55M |
| Operating Income | $544.13M |
| Net Income | $71.35M |
|
|
|
| EBITDA | $1.60B |
| Revenue/Share | $4.06 |
Cash Flow
| Operating CF | $1.28B |
| CapEx | $133.95M |
| Free Cash Flow | $1.15B |
|
|
|
| Book Value/Share | $11.93 |
| Tangible Book/Share | $10.89 |
| Equity/Share | $10.78 |
Technical Indicators
| RSI (14) | 60.59 Neutral |
| MACD |
0.09
Signal: 0.08
|
| Volatility | 25.12% |
| Trading Signal | Bullish |
Performance & Returns
| 1 Year | -2.48% |
| Sharpe Ratio | -0.17 Poor |
| Volatility (Ann.) | 23.24% Moderate |
| DOC (1Y) | -2.48% |
| S&P 500 (1Y) | +13.03% |
| Alpha (Excess Return) | -15.52% |
Sector Comparison (Real Estate)
| Metric | DOC | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 172.8 | 134.38 | 89% |
| P/B Ratio | 1.6 | 1.31 | 21% |
| ROE (%) | 0.91% | 11.26% | 18% |
| Net Margin (%) | 2.53% | 21.58% | 11% |
| Stock Score | 452 | 521.0 | 11% |
| 1Y Return (%) | -2.48 % | -2.75 % | 57% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DOC | $17.28 | $17.35 | $17.42 | $17.32 | $17.03 | $17.58 | 60.59 | 0.09 | 25.12% | 919544 | Weak Short | Price Below SMAs |
Candlestick Patterns
There wasn't any recognizable pattern for the DOC stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| DOC | The Hormuz Halt | Neutral | seekingalpha.com | Read More |
| DOC | Healthpeak (DOC) Up 6.3% Since Last Earnings Report: Can It Continue? | Neutral | zacks.com | Read More |
| DOC | Healthpeak Is Splitting Into Two. Here's What That Means For The Dividend Buffer | Neutral | feeds.benzinga.com | Read More |
| DOC | Seven S&P500 Ideal 'Safer' March Dividend Dogs | Neutral | seekingalpha.com | Read More |
| DOC | These S&P 500 Dividend Stocks Are Quietly Crushing the Index — And Paying You Monthly | Neutral | 247wallst.com | Read More |
Recent Insider Trading
No recent insider trading data available for DOC
Company Information
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
| CEO | Scott Brinker |
| Employees | 387 |
| Country | US |
| IPO Date | 1985-05-23 |
| Exchange | NYSE |
| Website | https://www.healthpeak.com |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
Similar Stocks (Real Estate - REIT - Healthcare Facilities)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category